![Drug that halves a woman's risk of breast cancer works for SEVEN YEARS after they stop taking it | Daily Mail Online Drug that halves a woman's risk of breast cancer works for SEVEN YEARS after they stop taking it | Daily Mail Online](https://i.dailymail.co.uk/1s/2019/12/13/08/22194456-0-image-a-11_1576227548704.jpg)
Drug that halves a woman's risk of breast cancer works for SEVEN YEARS after they stop taking it | Daily Mail Online
![Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial - The Lancet Oncology Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/49eb3bdf-e0df-4a9f-b5f2-51f115cb9c81/gr1.jpg)
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial - The Lancet Oncology
![Off-treatment bone mineral density changes in postmenopausal women receiving anastrozole for 5 years: 7-year results from the IBIS-II prevention trial | British Journal of Cancer Off-treatment bone mineral density changes in postmenopausal women receiving anastrozole for 5 years: 7-year results from the IBIS-II prevention trial | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-020-01228-2/MediaObjects/41416_2020_1228_Fig1_HTML.png)
Off-treatment bone mineral density changes in postmenopausal women receiving anastrozole for 5 years: 7-year results from the IBIS-II prevention trial | British Journal of Cancer
![Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial - The Lancet Oncology Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/2001022902/2003876107/gr1.gif)
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial - The Lancet Oncology
![How long should you stay on aromatase inhibitors after completing breast cancer treatment? | Everyday Health How long should you stay on aromatase inhibitors after completing breast cancer treatment? | Everyday Health](https://images.everydayhealth.com/images/cancer/breast-cancer/aromatase-inhibitors-to-prevent-breast-cancer-722x406.tmb-0.jpg?sfvrsn=5ef462b0_1)
How long should you stay on aromatase inhibitors after completing breast cancer treatment? | Everyday Health
![The adverse effects profiles for anastrozole and tamoxifen observed in... | Download Scientific Diagram The adverse effects profiles for anastrozole and tamoxifen observed in... | Download Scientific Diagram](https://www.researchgate.net/profile/Kefah-Mokbel/publication/8949984/figure/fig2/AS:669357566853134@1536598688459/The-adverse-effects-profiles-for-anastrozole-and-tamoxifen-observed-in-the-ATAC-study_Q640.jpg)